APA

Molendijk M. L., Bus B. A. A., Spinhoven P., Penninx B. W. J. H., Kenis G., Prickaerts J., Voshaar R. C. O. & Elzinga B. M. (20120305). Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. : Molecular psychiatry.

Chicago

Molendijk M L, Bus B A A, Spinhoven Ph, Penninx B W J H, Kenis G, Prickaerts J, Voshaar R C Oude and Elzinga B M. 20120305. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. : Molecular psychiatry.

Harvard

Molendijk M. L., Bus B. A. A., Spinhoven P., Penninx B. W. J. H., Kenis G., Prickaerts J., Voshaar R. C. O. and Elzinga B. M. (20120305). Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. : Molecular psychiatry.

MLA

Molendijk M L, Bus B A A, Spinhoven Ph, Penninx B W J H, Kenis G, Prickaerts J, Voshaar R C Oude and Elzinga B M. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. : Molecular psychiatry. 20120305.